SEC Form 4 · accession 0001209191-16-118820
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William J Robison
Director
Period of report
May 9, 2016
Accepted (ET)
May 10, 2016 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 9, 2016 | M | 3,333 | $4.78 | A | 177,196 | D | |
| Common Stock | holding | — | — | — | 173,863 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to buy) | $4.78 | May 9, 2016 | X | 3,333 | D | May 6, 2016 | May 6, 2020 | Common Stock | 3,333 | 6,667 | D |
| Stock Option (Right to Buy)F1 | $4.78 | holding | — | — | — | May 6, 2016 | May 6, 2020 | Common Stock | 10,000 | 6,667 | D |
Explanation of responses
- F1On May 6, 2015 Mr. Robison was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. On May 9, 2016, Mr. Robison exercised 3,333 of these options leaving a balance of 6,667 stock options.